Fig. 2. Inhibitor status according to hemophilia A phenotypes. The severer phenotypes patients have, the more frequent inhibitors the patients developed (P<0.001). However the proportion of persistent inhibitors to transient inhibitors was not significantly higher in severe patients in comparison with the mild and moderate patients (P=0.221). Abbreviations: PWH, patient with hemophilia; INH, inhibitor.